Dynavax Technologies
DVAX
#5117
Rank
โ‚ฌ1.59 B
Marketcap
13,61ย โ‚ฌ
Share price
0.00%
Change (1 day)
14.61%
Change (1 year)

Dynavax Technologies (DVAX) - Cash on Hand

Cash on Hand as of September 2025 : โ‚ฌ0.56 Billion

According to Dynavax Technologies 's latest financial reports the company has โ‚ฌ0.56 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Dynavax Technologies - Cash on Hand chart (from 2003 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31โ‚ฌ0.68 B2.16%
2023-12-31โ‚ฌ0.67 B15.36%
2022-12-31โ‚ฌ0.58 B20.75%
2021-12-31โ‚ฌ0.48 B259.28%
2020-12-31โ‚ฌ0.13 B-0.49%
2019-12-31โ‚ฌ0.13 B5.99%
2018-12-31โ‚ฌ0.12 B-20.44%
2017-12-31โ‚ฌ0.15 B106.58%
2016-12-31โ‚ฌ77.4 M-56.85%
2015-12-31โ‚ฌ0.17 B77.86%
2014-12-31โ‚ฌ0.10 B-26.46%
2013-12-31โ‚ฌ0.13 B44.96%
2012-12-31โ‚ฌ94.59 M7.8%
2011-12-31โ‚ฌ87.75 M61.77%
2010-12-31โ‚ฌ54.24 M111.65%
2009-12-31โ‚ฌ25.62 M-47.67%
2008-12-31โ‚ฌ48.98 M-18.96%
2007-12-31โ‚ฌ60.43 M9.5%
2006-12-31โ‚ฌ55.19 M-12.95%
2005-12-31โ‚ฌ63.4 M30.63%
2004-12-31โ‚ฌ48.53 M110.03%
2003-12-31โ‚ฌ23.11 M-17.85%
2002-12-31โ‚ฌ28.13 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Pfizer
PFE
โ‚ฌ11.47 B 1,918.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚ฌ10.56 B 1,758.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
โ‚ฌ3.75 B 561.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
โ‚ฌ6.70 B 1,079.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚ฌ5.00 B 780.19%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
โ‚ฌ6.73 B 1,084.75%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
โ‚ฌ4.00 B 603.85%๐Ÿ‡ฌ๐Ÿ‡ง UK
Agenus
AGEN
โ‚ฌ3.03 M-99.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
โ‚ฌ3.28 B 477.48%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel